News Results
There are 620,768 News Results
Oct 30, 2024
Biomarker cohort for delpacibart braxlosiran (del-brax), the first potential therapy to target DUX4, is measuring changes in DUX4 regulated biomarkers; del-brax 2 mg/kg will be administered every six weeks
Oct 30, 2024
The global insurance third party administrator market is set for explosive growth, with projections indicating a surge to $544.67 billion by 2031. This remarkable expansion, driven by the increase in...
Oct 30, 2024
-- Net sales of $130.2 million increased 9.7% year-over-year -- Record net sales of $44.3 million for the Precast Infrastructure and Engineered Systems segment ("Precast") -- Record gross profit of...
Oct 30, 2024
-- Acquisition of Altair Engineering Inc., a global leader in computational science and artificial intelligence software, strengthens Siemens' position as a leading technology company -- Creates the world's most complete...
Oct 31, 2024
MILWAUKEE, Oct. 31, 2024 /PRNewswire/ -- WEC Energy Group (NYSE: WEC) today reported net income of $240.1 million, or 76 cents per share, for the third quarter of 2024. This...
Oct 31, 2024
Testing the efficacy and safety of Intensity's lead drug candidate, INT230-6, when combined with Standard-of-Care versus Standard-of-Care alone The endpoint is the change in pathological complete response rates SHELTON, Conn....
Oct 31, 2024
With sights set on the world's most fascinating regions, the ultra-luxury line announces 2026 and 2027 itineraries on purpose-built expedition ships Seabourn Venture and Seabourn Pursuit
Oct 31, 2024
DENVER, Oct. 31, 2024 /PRNewswire/ -- SM Energy Company (the "Company") (NYSE: SM) today reported operating and financial results for the third quarter 2024 and provided certain full year and...
Oct 31, 2024
VICTORIA, BC, Oct. 31, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere(TM) technology to optimize drug...
